Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Avalo Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +4 vs. Q3 2024
- Shares held
- 7.53M
- +873.6K (+13.1%) vs. Q3 2024
- Total value
- $56.0M
- −$7.25M (−11.5%) vs. Q3 2024
- New holders
- 9
- 8 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 1,036,679 | $7.70M | 0.26% | +69,679+7.2% | Added |
| Ikarian Capital, LLC | 970,259 | $7.21M | 2.06% | −1000.0% | Reduced |
| OrbiMed Advisors LLC | 967,000 | $7.18M | 0.15% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 967,000 | $7.18M | 0.10% | 00.0% | Unchanged |
| Deep Track Capital, LP | 867,000 | $6.44M | 0.24% | −100,000−10.3% | Reduced |
| Affinity Asset Advisors, LLC | 550,765 | $4.09M | 0.64% | +505,765+1,123.9% | Added |
| Commodore Capital LP | 483,000 | $3.59M | 0.26% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 483,000 | $3.59M | 0.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 165,801 | $1.23M | 0.00% | +155,433+1,499.2% | Added |
| Boothbay Fund Management, LLC | 163,992 | $1.22M | 0.04% | −100−0.1% | Reduced |
| BlackRock, Inc. | 133,235 | $989.9K | 0.00% | +132,906+40,397.0% | Added |
| Royal Bank of Canada | 117,356 | $872.0K | 0.00% | +117,356 | New |
| Velan Capital Investment Management LP | 109,972 | $817.1K | 0.71% | +109,972 | New |
| Geode Capital Management, LLC | 104,853 | $779.1K | 0.00% | +94,742+937.0% | Added |
| UBS Group AG | 98,519 | $732.0K | 0.00% | +92,385+1,506.1% | Added |
| Allostery Investments LP | 73,314 | $544.7K | 1.07% | +73,314 | New |
| Sio Capital Management, LLC | 71,458 | $530.9K | 0.15% | 00.0% | Unchanged |
| Bank of Montreal | 60,000 | $445.8K | 0.00% | +60,000 | New |
| HRT Financial LP | 40,000 | $297.0K | 0.00% | +40,000 | New |
| Northern Trust Corp | 22,673 | $168.5K | 0.00% | +22,673 | New |
| Walleye Capital LLC | 19,477 | $144.7K | 0.00% | +19,477 | New |
| Marshall Wace, LLP | 15,323 | $113.8K | 0.00% | +15,323 | New |
| Bank of America Corp | 5,670 | $42.1K | 0.00% | +69+1.2% | Added |
| Tower Research Capital LLC (TRC) | 4,130 | $30.7K | 0.00% | +3,754+998.4% | Added |
| SBI Securities Co., Ltd. | 22 | $163 | 0.00% | +22 | New |
| Morgan Stanley | 10 | $74 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4 | $30 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $15 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2 | $15 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $14 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −539,079−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −5−100.0% | Sold out |